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Background
The aim of the present study was to assess the association
of the presence and amount of late gadolinium enhance-
ment (LGE) at cardiac magnetic resonance (CMR) with
cardiovascular adverse events in patients who survived the
first year after cardiac transplantation (HTx).
Methods
We enrolled 48 patients (mean age, 54.7 ± 14.6 years;
37 men) at various stages after HTx (median 9.88 yrs).
All patients underwent standard CMR at 1.5 T, images
were acquired with retrospective ECG gating and during
repeated single breath-holds. Balanced steady-state free
precession were used to obtain cine images (echo time/
repetition time, 1.6/3.2 ms; flip angle, 60°; pixel size,
2.4 × 1.4 mm, slice thickness 8 mm, gap 2 mm) in three
long-axis planes and in contiguous short-axis slices.
LGE images were acquired in matching short-axis and
long axis planes starting 10 min after intravenous injec-
tion of gadolinium-DTPA (Schering©, Berlin, Germany;
0.15 mmol/kg) and using a segmented inversion-recov-
ery gradient echo sequence. The primary endpoint was
a composite of first occurrence of major cardiovascular
adverse events which required hospitalization (MACE):
CV death, congestive heart failure, redo transplant,
arrhythmias requiring hospitalization (high degree A-V
block, sustained supraventricular tachyarrhythmias, sus-
tained ventricular tachycardia, bradycardia requiring
pace-maker implantation), coronary revascularization,
the secondary endpoints were all-cause death and cardi-
ovascular death. Survival of patients was estimated by
Kaplan-Meier analysis, for each end point Cox multi-
variate models were constructed.
Results
Myocardial LGE was detected in 26 patients (54%) with a
median amount of 9.16 g (IQR 3.01 to 21.21) correspond-
ing to 6.4% (IQR 2. 3 to 13.25) of LV mass. Cardiac
allograft vasculopathy (CAV) was diagnosed in 54% LGE
positive and 23% LGE negative patients (p = 0.057).
Primary and secondary end-points were recorded during
the follow-up period median 5.16 years (IQR 4.33 to 6.52).
Ten patients died and 26 were readmitted because of
MACE. LGE presence at CMR was associated with an
increased risk of sustaining an index event during follow
up shown by the Kaplan-Meier survival curves (Figure,
logrank test p = 0.003). Multivariate Cox analysis identi-
fied as independent predictors of MACE a diagnosis of
CAV (HR 3.63;p = 0.0039), left ventricular end systolic
volume index (HR1.04; p = 0.008), LGE mass (HR1.04;
p = 0.0007), LGE % of left ventricular mass (HR1.083;
p = 0.0002). Independent predictors of all-cause death
were CAV (HR 6.33;p = 0.0201), LGE mass (HR1.04;
p = 0.005), LGE % of left ventricular mass (HR1.075;
p = 0.007) whereas cardiovascular death was predicted by
CAV (HR 10.8; p = 0.0263) and LGE mass (HR1.04;
p = 0.0037).
Conclusions
In survivors after 1 year from HTx the presence of CAV
and the amount of LGE are strongly associated with
MACE and mortality.
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Figure 1 Kaplan-Meier event-free survival curve for occurrence of MACE patients grouped by presence or absence of LGE.
Pedrotti et al. Journal of Cardiovascular Magnetic
Resonance 2016, 18(Suppl 1):O63
http://www.jcmr-online.com/content/18/S1/O63
Page 2 of 2
